about
Detection of obstructive uropathy and assessment of differential renal function using two functional magnetic resonance urography tools. A comparison with diuretic renal scintigraphy in infants and childrenInfluence of rigid coregistration of PET and CT data on metabolic volumetry: a user's perspectiveQuantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLCThe association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients.Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients.The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction.Degenerative changes after posterior cruciate ligament reconstruction are irrespective of posterior knee stability: MRI-based long-term results.Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on 123I-MIBG SPECT predict the outcome?A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma.Ga-68-PSMA PET/CT in treatment-naïve patients with prostate cancer: Which clinical parameters and risk stratification systems best predict PSMA-positive metastases?Interobserver variability of image-derived arterial blood SUV in whole-body FDG PETI-123-MIBG scintigraphy in patients with neuroblastomaPoint Spread Function Reconstruction for Integrated 18F-FET PET/MRI in Patients With Glioma: Does It Affect SUVs and Respective Tumor-to-Background Ratios?Comparison of glomerular filtration rate (GFR) with Tc-99m-DTPA and tubular extraction rate (TER) with Tc-99m-MAG3 in potential living kidney donors: Feasibility of a one-day protocolValidation of Independent Prognostic Value of Asphericity of 18F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative IntentThe association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATEAssessment of the tibial slope is highly dependent on the type and accuracy of the preceding acquisitionReconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF)
P50
Q28364855-6AA4287B-39FE-4CF6-83B9-DE6D72790254Q30724225-7F7EF575-8F5B-41FB-A1FA-7379E271C52DQ34695293-30274671-2375-43CC-B086-8F11FA866E9BQ35593955-6BB0B357-8859-42BE-8436-5B877FF92C0CQ38613594-33279D20-C240-4566-81C6-3B736FC2094CQ38841174-7905C724-AB77-483C-87FE-3B9AB7DFF060Q40330165-6EA6AE5E-2C2E-43E8-8799-991892C9A4C2Q40392850-6840D6FB-F5BB-42EF-BEA2-30FDC17970B7Q47568684-156A757C-B763-431B-A997-1F52C356E743Q48238960-4024EE90-A222-4B7B-BBB9-5851025332CBQ49853629-5122B050-70D2-4C53-B2A2-748D427DAA90Q52803394-A579B0CA-72B5-426F-A538-EE2A36D5C824Q56963215-65C99B0A-7435-4C8A-8BAA-CDA7F8D1E6EDQ64067244-11D203BB-F0EF-4732-90B4-FDB873035B39Q88047922-79D58D3C-7381-458C-B93D-10596D5FB3F7Q90613751-0A86B8A4-AC47-4980-B7A3-24C651E1EE65Q90632273-ACE49448-ADD0-4C2F-AFC8-F199E98E843CQ91991433-4A4865AF-A12B-4F1F-BB8E-D9DF4DCFC954Q92039466-3EDC766D-5AE9-4FC3-8F53-E6B1ECA693F5Q92138397-098F22D7-1760-4AC6-9A79-99B18CD969B9Q92566070-4AD9FF7B-B790-4423-A8EC-B338D8134CD0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Julian Rogasch
@ast
Julian Rogasch
@en
Julian Rogasch
@es
Julian Rogasch
@nl
type
label
Julian Rogasch
@ast
Julian Rogasch
@en
Julian Rogasch
@es
Julian Rogasch
@nl
prefLabel
Julian Rogasch
@ast
Julian Rogasch
@en
Julian Rogasch
@es
Julian Rogasch
@nl
P106
P1153
55979413800
P31
P496
0000-0002-0817-6532